115 related articles for article (PubMed ID: 37401893)
1. Pneumococcal vaccination coverage among US adults enrolled in Medicaid and newly diagnosed with underlying medical conditions.
Liu J; Johnson KD; Shoener Dunham L
Expert Rev Vaccines; 2023; 22(1):596-607. PubMed ID: 37401893
[TBL] [Abstract][Full Text] [Related]
2. Pneumococcal vaccination coverage among adults newly diagnosed with underlying medical conditions and regional variation in the U.S.
Ostropolets A; Shoener Dunham L; Johnson KD; Liu J
Vaccine; 2022 Aug; 40(33):4856-4863. PubMed ID: 35803847
[TBL] [Abstract][Full Text] [Related]
3. Pneumococcal Vaccine Coverage in Adults Aged 19-64 Years, Newly Diagnosed With Chronic Conditions in the U.S.
Petigara T; Zhang D
Am J Prev Med; 2018 May; 54(5):630-636. PubMed ID: 29551328
[TBL] [Abstract][Full Text] [Related]
4. Pneumococcal vaccination coverage among adults aged 19 to 64 years with immuno-compromising conditions, cerebrospinal fluid (CSF) leaks, or cochlear implants in the US.
Deb A; Mohanty S; Ou W; Rajagopalan S; Johnson KD
Expert Rev Vaccines; 2021 Mar; 20(3):331-345. PubMed ID: 33724134
[No Abstract] [Full Text] [Related]
5. Regional factors associated with pneumococcal vaccination coverage among U.S. adults with underlying chronic or immunocompromising conditions.
Liu J; Shoener Dunham L; Johnson KD
Hum Vaccin Immunother; 2023 Dec; 19(1):2194779. PubMed ID: 37038308
[TBL] [Abstract][Full Text] [Related]
6. Pneumococcal vaccine coverage among individuals aged 18 to 64 years old with underlying medical conditions in the UK: a retrospective database analysis.
Matthews I; Lu X; Xia Q; Black W; Nozad B
BMC Public Health; 2020 Oct; 20(1):1584. PubMed ID: 33087085
[TBL] [Abstract][Full Text] [Related]
7. Pneumococcal vaccination coverage in individuals (16-59 years) with a newly diagnosed risk condition in Germany.
Deb A; Podmore B; Barnett R; Beier D; Galetzka W; Qizilbash N; Haeckl D; Boellinger T; Johnson KD; Weiss T
BMC Infect Dis; 2022 Sep; 22(1):753. PubMed ID: 36171549
[TBL] [Abstract][Full Text] [Related]
8. Clinical and economic burden of pneumococcal disease in US adults aged 19-64 years with chronic or immunocompromising diseases: an observational database study.
Zhang D; Petigara T; Yang X
BMC Infect Dis; 2018 Aug; 18(1):436. PubMed ID: 30157781
[TBL] [Abstract][Full Text] [Related]
9. Streptococcus pneumoniae-related illnesses in young children: secular trends and regional variation.
Poehling KA; Szilagyi PG; Edwards K; Mitchel E; Barth R; Hughes H; Lafleur B; Schaffer SJ; Schwartz B; Griffin MR
Pediatr Infect Dis J; 2003 May; 22(5):413-8. PubMed ID: 12792380
[TBL] [Abstract][Full Text] [Related]
10. Pneumococcal vaccination coverage in France by general practitioners in adults with a high risk of pneumococcal disease.
Kopp A; Mangin O; Gantzer L; Lekens B; Simoneau G; Ravelomanantsoa M; Evans J; Bergmann JF; Sellier P
Hum Vaccin Immunother; 2021 Jan; 17(1):162-169. PubMed ID: 32429734
[No Abstract] [Full Text] [Related]
11. Pneumococcal and influenza vaccination coverage among at-risk adults: A 5-year French national observational study.
Wyplosz B; Fernandes J; Sultan A; Roche N; Roubille F; Loubet P; Fougère B; Moulin B; Duhot D; Vainchtock A; Raguideau F; Lortet-Tieulent J; Blanc E; Moïsi J; Goussiaume G
Vaccine; 2022 Aug; 40(33):4911-4921. PubMed ID: 35811205
[TBL] [Abstract][Full Text] [Related]
12. Pneumococcal vaccination coverages by age, sex and specific underlying risk conditions among middle-aged and older adults in Catalonia, Spain, 2017.
Vila-Córcoles A; Ochoa-Gondar O; de Diego C; Satué E; Vila-Rovira A; Aragón M
Euro Surveill; 2019 Jul; 24(29):. PubMed ID: 31339099
[TBL] [Abstract][Full Text] [Related]
13. Influenza and Pneumococcal Vaccination Uptake in Patients with Rheumatoid Arthritis Treated with Immunosuppressive Therapy in the UK: A Retrospective Cohort Study Using Data from the Clinical Practice Research Datalink.
Costello R; Winthrop KL; Pye SR; Brown B; Dixon WG
PLoS One; 2016; 11(4):e0153848. PubMed ID: 27096429
[TBL] [Abstract][Full Text] [Related]
14. Pneumococcal vaccination patterns among persons aged 65 years or older in the United States: A retrospective database analysis.
Yang X; Zhang D; Ou W
Vaccine; 2018 Nov; 36(49):7574-7579. PubMed ID: 30391053
[TBL] [Abstract][Full Text] [Related]
15. Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults.
Rehm SJ; Farley MM; File TM; Hall WJ; Hopkins R; Levine OS; Nichol KL; Nuorti P; Zimmerman RK; Schaffner W
Postgrad Med; 2009 Nov; 121(6):101-5. PubMed ID: 19940420
[TBL] [Abstract][Full Text] [Related]
16. Influenza, pneumococcal, and tetanus toxioid vaccination of adults--United States, 1993-7.
Singleton JA; Greby SM; Wooten KG; Walker FJ; Strikas R
MMWR CDC Surveill Summ; 2000 Sep; 49(9):39-62. PubMed ID: 11016877
[TBL] [Abstract][Full Text] [Related]
17. Recurrent invasive pneumococcal disease in children--host factors and vaccination response.
Ingels HA
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183055
[TBL] [Abstract][Full Text] [Related]
18. Rates and costs of invasive pneumococcal disease and pneumonia in persons with underlying medical conditions.
Weycker D; Farkouh RA; Strutton DR; Edelsberg J; Shea KM; Pelton SI
BMC Health Serv Res; 2016 May; 16():182. PubMed ID: 27177430
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of administering 13-valent pneumococcal conjugate vaccine in addition to 23-valent pneumococcal polysaccharide vaccine to adults with immunocompromising conditions.
Cho BH; Stoecker C; Link-Gelles R; Moore MR
Vaccine; 2013 Dec; 31(50):6011-21. PubMed ID: 24148572
[TBL] [Abstract][Full Text] [Related]
20. Pneumococcal vaccination coverage and adherence to recommended dosing schedules in adults: a repeated cross-sectional study of the INTEGO morbidity registry.
Janssens A; Vaes B; Abels C; Crèvecoeur J; Mamouris P; Merckx B; Libin P; Van Pottelbergh G; Neyens T
BMC Public Health; 2023 Jun; 23(1):1104. PubMed ID: 37286969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
